Last updated on March 2020

The Individualized M(X) Drug-resistant TB Treatment Strategy Study

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: drug-resistant tuberculosis
  • Age: Between 18 - 100 Years
  • Gender: Male or Female

Inclusion Criteria

  • Adults 18 years of age
  • Pulmonary Tuberculosis
  • Microbiological confirmation [e.g. GeneXpert Mycobacterium Tuberculosis (MTB) detected and Rifampicin (RIF) resistant and / Line Probe Assay (LPA)] of Multi drug-resistant tuberculosis (MDR-TB) / Pre-Extremely drug-resistant tuberculosis (Pre-XDR-TB) / Extremely drug-resistant tuberculosis (XDR-TB)
  • Capacity for providing informed consent
  • HIV status - HIV infected and uninfected patients are allowed in the study:
  • Patients already on antiretroviral treatment (ART) will be allowed in the study. The antiretroviral treatment regimen will be evaluated for any contraindications to the drugs used.
  • HIV infected patients at any CD4 count irrespective of antiretroviral treatment commencement and duration will be included in the study

Exclusion Criteria:

  • Persons suffering from any serious acute condition.
  • Any other chronic or clinically significant medical condition that in the opinion of the attending clinician would render the patient unsuitable for participation in the study.

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.